ICAM1 and Graves disease: Many previous studies have shown increased levels of the soluble form of both ICAM-1 and E-selectin released into the systemic circulation that correlate with the activity and severity of several diseases such as rheumatoid arthritis [23,24], Grave’s disease [25,26] and systemic vasculitis [27].